Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy W Robison

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Bioanalysis|November 19, 2010
Metabolites in safety testingTimothy W Robison, Abigail Jacobs
Environmental and Molecular Mutagenesis|June 12, 2021
Mutational signatures in T-lymphocytes of rats treated with N-propyl-N-nitrosourea and procarbazineJavier R Revollo, Page B McKinzie, Timothy W Robison, et al.
Regulatory Toxicology and Pharmacology : RTP|November 22, 2025
Assessing carcinogenic outcomes following short-term exposure to potentially DNA-reactive drugs: Are available data sufficient to inform risk assessment?Dayton M Petibone, Jennifer M Shemansky, Timothy W Robison, et al.
Archives of Toxicology|May 20, 2023
Evaluation of mutagenic susceptibility of different stages in germ cell development of Caenorhabditis elegans using whole genome sequencingHua Du, Bohu Pan, Alexander W Alund, et al.
Environmental and Molecular Mutagenesis|August 10, 2011
Monitoring humans for somatic mutation in the endogenous PIG-a gene using red blood cellsVasily N Dobrovolsky, Rosalie K Elespuru, C Anita H Bigger, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|November 12, 2019
Pig-a mutations in bone marrow erythroblasts of rats treated with 7,12-dimethyl-benz[a]anthraceneJavier R Revollo, Azra Dad, Mason G Pearce, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|August 29, 2021
Appropriate in vivo follow-up assays to an in vitro bacterial reverse mutation (Ames) test positive investigational drug candidate (active pharmaceutical ingredient), drug-related metabolite, or drug-related impurityTimothy W Robison, Robert H Heflich, Mugimane G Manjanatha, et al.
Journal of Toxicology and Environmental Health. Part A|September 28, 2020
Performance of HepaRG and HepG2 cells in the high-throughput micronucleus assay for in vitro genotoxicity assessmentXiaoqing Guo, Ji-Eun Seo, Dayton Petibone, et al.
Environmental and Molecular Mutagenesis|August 10, 2018
Analysis of mutation in the rat Pig-a assay: I) studies with bone marrow erythroid cellsJavier R Revollo, Mason G Pearce, Azra Dad, et al.
Cancer Medicine|January 12, 2024
Erythrocyte PIG-A mutant frequencies in cancer patients receiving cisplatinVasily N Dobrovolsky, Omar T Atiq, Robert H Heflich, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Bioanalysis|November 19, 2010
Metabolites in safety testingTimothy W Robison, Abigail Jacobs
Environmental and Molecular Mutagenesis|June 12, 2021
Mutational signatures in T-lymphocytes of rats treated with N-propyl-N-nitrosourea and procarbazineJavier R Revollo, Page B McKinzie, Timothy W Robison, et al.
Regulatory Toxicology and Pharmacology : RTP|November 22, 2025
Assessing carcinogenic outcomes following short-term exposure to potentially DNA-reactive drugs: Are available data sufficient to inform risk assessment?Dayton M Petibone, Jennifer M Shemansky, Timothy W Robison, et al.
Archives of Toxicology|May 20, 2023
Evaluation of mutagenic susceptibility of different stages in germ cell development of Caenorhabditis elegans using whole genome sequencingHua Du, Bohu Pan, Alexander W Alund, et al.
Environmental and Molecular Mutagenesis|August 10, 2011
Monitoring humans for somatic mutation in the endogenous PIG-a gene using red blood cellsVasily N Dobrovolsky, Rosalie K Elespuru, C Anita H Bigger, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|November 12, 2019
Pig-a mutations in bone marrow erythroblasts of rats treated with 7,12-dimethyl-benz[a]anthraceneJavier R Revollo, Azra Dad, Mason G Pearce, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|August 29, 2021
Appropriate in vivo follow-up assays to an in vitro bacterial reverse mutation (Ames) test positive investigational drug candidate (active pharmaceutical ingredient), drug-related metabolite, or drug-related impurityTimothy W Robison, Robert H Heflich, Mugimane G Manjanatha, et al.
Journal of Toxicology and Environmental Health. Part A|September 28, 2020
Performance of HepaRG and HepG2 cells in the high-throughput micronucleus assay for in vitro genotoxicity assessmentXiaoqing Guo, Ji-Eun Seo, Dayton Petibone, et al.
Environmental and Molecular Mutagenesis|August 10, 2018
Analysis of mutation in the rat Pig-a assay: I) studies with bone marrow erythroid cellsJavier R Revollo, Mason G Pearce, Azra Dad, et al.
Cancer Medicine|January 12, 2024
Erythrocyte PIG-A mutant frequencies in cancer patients receiving cisplatinVasily N Dobrovolsky, Omar T Atiq, Robert H Heflich, et al.
Pageof 2